Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality

Authors

  • ILAN GOLDENBERG M.D.,

    1. Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    2. Heart Institute and Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel
    Search for more papers by this author
  • ARTHUR J. MOSS M.D.

    1. Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Search for more papers by this author

  • J Cardiovasc Electrophysiol, Vol. 19, pp. 1281–1283, December 2008.

  • Dr. Moss is the recipient of a research grant from Boston Scientific for the MADIT-II trial.

Address for correspondence: Ilan Goldenberg, M.D., Heart Research Follow-Up Program, University of Rochester Medical Center, Box 653, Rochester, NY 14642, USA. Fax: 585-273-5283; E-mail: ilan.goldenberg@heart.rochester.edu

No abstract is available for this article.

Ancillary